AnaptysBio Reports Positive Topline Data from Phase 2a

ANAB: AnaptysBio, Inc.
2018-09-24 06:30:00
AnaptysBio Reports Positive Topline Data from Phase 2a Proof-of-Concept Clinical Trial of Etokimab in Severe Eosinophilic Asthma